Perioperative Use of Dobutamine in Cardiac Surgery and Adverse Cardiac Outcome
- 1 June 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 108 (6) , 979-987
Abstract
Background: Catecholamines, mainly dobutamine, are often administered without institutional guidelines or prespecified algorithms in cardiac surgery. The current study assessed the consequences on clinical outcome of catecholamines simply based on the clinical judgment of the anesthesiologists after cardiopulmonary bypass in adult cardiac surgery. Methods: Consecutive patients were enrolled in a nonrandomized cohort study. Factors associated with perioperative use of catecholamines and with outcomes were recorded prospectively to conduct bias adjustment, including propensity scores. Major cardiac morbidity (i.e., ventricular arrhythmia, use of an intraaortic balloon pump and postoperative myocardial infarction) and all-cause intrahospital mortality were the primary and secondary endpoints, respectively. Results are expressed as odds ratio (OR) [95% confidence interval]. Results: During the study, 84 of 657 patients (13%) received catecholamines, most often dobutamine (76 of 84, 90%). A higher incidence of both major cardiac morbidity (30 vs. 9%; P < 0.001; OR, 4.2 [2.5-7.3]) and all-cause intrahospital mortality (8 vs. 1%; P < 0.001; OR, 12.9 [3.7-45.2]) was observed in the catecholamine group compared with the control group. After adjusting for channeling bias and confounding factors, catecholamine administration remained significantly associated with major cardiac morbidity after propensity score stratification (OR, 2.1 [1.0-4.4]; P < 0.05), propensity score covariance analysis (OR, 2.3 [1.0-5.0]; P < 0.05), marginal structural models (OR, 1.8 [1.3-2.5]; P < 0.001), and propensity score matching (OR, 3.0 [1.2-7.3]; P < 0.02), but not with all-cause intrahospital mortality. Conclusions: These results suggest that dobutamine should only be administered when the benefit is judged to outweigh the risks.Keywords
This publication has 28 references indexed in Scilit:
- Hemodynamic management of patients in the first 24 hours after cardiac surgeryCritical Care Medicine, 2005
- Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery – a systematic literature reviewCritical Care, 2005
- French multicentre survey on the use of inotropes after cardiac surgery.Critical Care, 2005
- Inotrope use at separation from cardiopulmonary bypass and the role of prebypass TEEJournal of Cardiothoracic and Vascular Anesthesia, 2004
- Predictors of inotrope use during separation from cardiopulmonary bypassJournal of Cardiothoracic and Vascular Anesthesia, 2004
- The Safety of Intraoperative Transesophageal Echocardiography: A Case Series of 7200 Cardiac Surgical PatientsAnesthesia & Analgesia, 2001
- Effects of Dobutamine on Hemodynamics and Left Ventricular Performance after Cardiopulmonary Bypass in Cardiac Surgical PatientsAnesthesiology, 1999
- Factors That Predict the Use of Positive Inotropic Drug Support After Cardiac Valve SurgeryAnesthesia & Analgesia, 1998
- Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgeryJournal of Cardiothoracic and Vascular Anesthesia, 1992
- Preoperative and Intraoperative Predictors of Inotropic Support and Long-Term Outcome in Patients Having Coronary Artery Bypass GraftingAnesthesia & Analgesia, 1991